The Company is authorized to issue an unlimited number of common shares.

 

 

 

On the Company entered into an “At-The-Market” Facility (“ATM”) equity distribution agreement with Cantor Fitzgerald acting as sole agent. Under the terms of this facility, the Company from time to time, sell shares of our common stock having an aggregate offering value of up to million through Cantor Fitzgerald on the Nasdaq Capital Market.

 

During the - and -month period ended the Company issued shares under this ATM equity facility at an average price of for gross proceeds of million ( million net of share issue costs). Costs associated with the proceeds consisted of a cash commission.

 

 

On the Company entered into the Aspire Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of of Common Shares over approximately months. Pursuant to the terms of this agreement, on Aspire Capital purchased Common Shares for gross proceeds of thousand ( thousand net of cash share issue costs). The Company also issued Common Shares to Aspire Capital in consideration for entering into the Aspire Purchase Agreement. On a cumulative basis to the Company has raised a total of million gross proceeds under the Aspire Purchase Agreement.

 

During the months ended the Company issued common shares under the Aspire Purchase Agreement at an average price of per share for gross and net proceeds of approximately million.

 

 

On the Company entered into the Aspire Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of million of Common Shares over approximately months. Pursuant to the terms of this agreement, on the Company issued Common Shares (“Commitment Shares”) to Aspire Capital in consideration for entering into the Aspire Purchase Agreement. The Company recorded thousand in general and administrative expenses related to the issuance of the Commitment Shares. As at the Company had issued any shares under the Aspire Purchase Agreement, other than the Commitment Shares.

 

 

On Aptose entered into an ATM equity facility with Cowen and Company, LLC, acting as sole agent. Under the terms of the ATM, Aptose was permitted to sell Common Shares having an aggregate offering value of million on NASDAQ. The ATM expired on and as at that date the Company had issued a cumulative million of Common Shares pursuant to this facility.

 

During the months ended the Company issued common shares under this ATM equity facility at an average price of per share for gross proceeds of approximately million ( million net of share issue costs). Costs associated with the proceeds included a cash commission as well as legal and accounting fees.

 

 

Loss per common share is calculated using the weighted average number of common shares outstanding for the - and -month periods ending and calculated as follows:

 

		Three months ended June 30,								Six months ended June 30,
			2018				2017				2018				2017
Issued common shares, beginning of period			32,225				18,944				27,502				15,722
Effect of ATM issuances			459				2,362				231				3,651
Effect of shares issued pursuant to share purchase agreements			1,257				-				3,007				-
Effect of exercise of stock options			9				-				4				-
Effect of RSUs redemptions			-				3				-				2
			33,950				21,309				30,744				19,375

 

The effect of any potential exercise of our stock options outstanding during the period has been excluded from the calculation of diluted loss per common share as it would be anti-dilutive.